Zalospirone

Zalospirone
Systematic (IUPAC) name
(3aα,4α,4aβ,6aβ,7α,7aα)-Hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-etheno-1H-cyclobut[f]isoindole-1,3(2H)-dione
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Uncontrolled
Pharmacokinetic data
Biological half-life 1-4 hours
Identifiers
CAS Number 114298-18-9
ATC code none
PubChem CID 163925
IUPHAR/BPS 58
ChemSpider 143768
UNII 0449O95Z1J YesY
Chemical data
Formula C24H29N5O2
Molar mass 419.519 g/mol
  (verify)

Zalospirone (WY-47,846) is a selective 5-HT1A partial agonist of the azapirone chemical class.[1][2] It was found to be effective in the treatment of anxiety and depression in clinical trials, but a high proportion of subjects dropped out due to side effects and development was subsequently never completed.[3]

See also

References

  1. Gleeson, S; Barrett, JE (1990). "5-HT1A agonist effects on punished responding of squirrel monkeys". Pharmacology, Biochemistry, and Behavior 37 (2): 335–7. doi:10.1016/0091-3057(90)90344-H. PMID 1981937.
  2. Singh, A; Lucki, I (1993). "Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors". Neuropharmacology 32 (4): 331–40. doi:10.1016/0028-3908(93)90153-T. PMID 8497336.
  3. Rickels, K; Derivan, A; Kunz, N; Pallay, A; Schweizer, E (1996). "Zalospirone in major depression: a placebo-controlled multicenter study". Journal of Clinical Psychopharmacology 16 (3): 212–7. doi:10.1097/00004714-199606000-00004. PMID 8784652.


This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.